A new Medicare program is making select GLP-1 weight loss drugs more affordable for eligible patients, with costs as low as ...

Revisions to the US Centers for Medicare & Medicaid Services’ (CMS) competitive bidding programme (CBP) have been welcomed by the medtech industry, despite remaining concerns. The CMS has outlined ...

For Medicare beneficiaries prescribed a glucagon-like petide-1 (GLP-1) receptor agonist, eligibility rules are far from ...

The top weight-loss drug manufacturers are promoting the new Medicare GLP-1 Bridge as the Trump administration takes a ...

Some Medicare beneficiaries are getting access to weight loss drugs this month through a so-called Bridge program. But ...

A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out if you qualify.

A new Medicare program offers coverage for weight loss drugs like Wegovy and Zepbound for eligible seniors.

The virtual care organization is concerned that with the proposed changes to the 2027 Physician Fee Schedule, the Centers for ...